{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:15:06Z","timestamp":1794003306858,"version":"4.8.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Peritoneal metastasis is the leading cause of death for gastrointestinal cancers. The native and therapy-induced ascites ecosystems are not fully understood. Here, we characterize single-cell transcriptomes of 191,987 ascites cancer\/immune cells from 35 patients with\/without gastric cancer peritoneal metastasis (GCPM). During GCPM progression, an increase is seen of monocyte-like dendritic cells (DCs) that are pro-angiogenic with reduced antigen-presenting capacity and correlate with poor gastric cancer (GC) prognosis. We also describe the evolution of monocyte-like DCs and regulatory and proliferative T cells following therapy. Moreover, we track GC evolution, identifying high-plasticity GC clusters that exhibit a propensity to shift to a high-proliferative phenotype. Transitions occur via the recently described, autophagy-dependent plasticity program, paligenosis. Two autophagy-related genes (<jats:italic>MARCKS<\/jats:italic> and <jats:italic>TXNIP<\/jats:italic>) mark high-plasticity GC with poorer prognosis, and autophagy inhibitors induce apoptosis in patient-derived organoids. Our findings provide insights into the developmental trajectories of cancer\/immune cells underlying GCPM progression and therapy resistance.<\/jats:p>","DOI":"10.1038\/s41467-023-36310-9","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T07:03:26Z","timestamp":1676358206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9886-7152","authenticated-orcid":false,"given":"Xuan-Zhang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jiao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Xu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Xi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jie","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Jia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0402-4662","authenticated-orcid":false,"given":"Jason C.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Feng","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0557-3097","authenticated-orcid":false,"given":"Zhen-Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"36310_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA: Cancer J. Clin."},{"key":"36310_CR2","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s12029-020-00419-7","volume":"52","author":"T Kus","year":"2021","unstructured":"Kus, T. et al. Prediction of peritoneal recurrence in patients with gastric cancer: a multicenter study. J. Gastrointest. Cancer 52, 634\u2013642 (2021).","journal-title":"J. Gastrointest. Cancer"},{"key":"36310_CR3","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s11605-018-3983-7","volume":"23","author":"M Nakamura","year":"2019","unstructured":"Nakamura, M. et al. Conversion surgery for gastric cancer with peritoneal metastasis based on the diagnosis of second-look staging laparoscopy. J. Gastrointest. Surg. 23, 1758\u20131766 (2019).","journal-title":"J. Gastrointest. Surg."},{"key":"36310_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/jso.24912","volume":"117","author":"D Mizrak Kaya","year":"2018","unstructured":"Mizrak Kaya, D. et al. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma. J. Surg. Oncol. 117, 678\u2013684 (2018).","journal-title":"J. Surg. Oncol."},{"key":"36310_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10120-021-01237-x","volume":"25","author":"Y Takahashi","year":"2022","unstructured":"Takahashi, Y. et al. Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08). Gastric Cancer 25, 235\u2013244 (2022).","journal-title":"Gastric Cancer"},{"key":"36310_CR6","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1245\/s10434-020-08842-7","volume":"27","author":"MG White","year":"2020","unstructured":"White, M. G. et al. Factors associated with resection and survival after laparoscopic HIPEC for peritoneal gastric cancer metastasis. Ann. Surg. Oncol. 27, 4963\u20134969 (2020).","journal-title":"Ann. Surg. Oncol."},{"key":"36310_CR7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1245\/s10434-018-07140-7","volume":"26","author":"TE Newhook","year":"2019","unstructured":"Newhook, T. E. et al. Laparoscopic hyperthermic intraperitoneal chemotherapy is safe for patients with peritoneal metastases from gastric cancer and may lead to gastrectomy. Ann. Surg. Oncol. 26, 1394\u20131400 (2019).","journal-title":"Ann. Surg. Oncol."},{"key":"36310_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10120-014-0417-4","volume":"18","author":"T Saito","year":"2015","unstructured":"Saito, T. et al. Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer. Gastric Cancer 18, 711\u2013719 (2015).","journal-title":"Gastric Cancer"},{"key":"36310_CR9","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/s41388-021-01988-y","volume":"40","author":"S Du","year":"2021","unstructured":"Du, S. et al. Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C\/EBPbeta-mediated PDGFB autocrine and paracrine signaling. Oncogene 40, 5764\u20135779 (2021).","journal-title":"Oncogene"},{"key":"36310_CR10","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.7150\/thno.46001","volume":"10","author":"G Ye","year":"2020","unstructured":"Ye, G. et al. Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis. Theranostics 10, 7545\u20137560 (2020).","journal-title":"Theranostics"},{"key":"36310_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41416-020-0898-3","volume":"123","author":"M Natsume","year":"2020","unstructured":"Natsume, M. et al. Omental adipocytes promote peritoneal metastasis of gastric cancer through the CXCL2-VEGFA axis. Br. J. Cancer 123, 459\u2013470 (2020).","journal-title":"Br. J. Cancer"},{"key":"36310_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02990-4","volume":"11","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Single-cell transcriptomics provides new insights into the role of fibroblasts during peritoneal fibrosis. Clin. Transl. Med. 11, e321 (2021).","journal-title":"Clin. Transl. Med."},{"key":"36310_CR13","doi-asserted-by":"publisher","first-page":"eaav5341","DOI":"10.1126\/scitranslmed.aav5341","volume":"11","author":"M Si","year":"2019","unstructured":"Si, M. et al. Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis. Sci. Transl. Med. 11, eaav5341 (2019).","journal-title":"Sci. Transl. Med."},{"key":"36310_CR14","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.2147\/OTT.S245663","volume":"13","author":"G Pan","year":"2020","unstructured":"Pan, G. et al. Discovering biomarkers in peritoneal metastasis of gastric cancer by metabolomics. OncoTargets Ther. 13, 7199\u20137211 (2020).","journal-title":"OncoTargets Ther."},{"key":"36310_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ags3.12296","volume":"4","author":"H Ohzawa","year":"2020","unstructured":"Ohzawa, H. et al. Exosomal microRNA in peritoneal fluid as a biomarker of peritoneal metastases from gastric cancer. Ann. Gastroenterol. Surg. 4, 84\u201393 (2020).","journal-title":"Ann. Gastroenterol. Surg."},{"key":"36310_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2019.04.034","volume":"457","author":"Y Hu","year":"2019","unstructured":"Hu, Y. et al. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer. Cancer Lett. 457, 142\u2013150 (2019).","journal-title":"Cancer Lett."},{"key":"36310_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-020-1125-8","volume":"27","author":"R Wang","year":"2021","unstructured":"Wang, R. et al. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat. Med. 27, 141\u2013151 (2021).","journal-title":"Nat. Med."},{"key":"36310_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","volume":"69","author":"R Wang","year":"2020","unstructured":"Wang, R. et al. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut 69, 18\u201331 (2020).","journal-title":"Gut"},{"key":"36310_CR19","doi-asserted-by":"publisher","first-page":"e98311","DOI":"10.15252\/embj.201798311","volume":"37","author":"SG Willet","year":"2018","unstructured":"Willet, S. G. et al. Regenerative proliferation of differentiated cells by mTORC1-dependent paligenosis. EMBO J. 37, e98311 (2018).","journal-title":"EMBO J."},{"key":"36310_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-physiol-061121-035954","volume":"84","author":"JW Brown","year":"2022","unstructured":"Brown, J. W., Cho, C. J. & Mills, J. C. Paligenosis: cellular remodeling during tissue repair. Annu. Rev. Physiol. 84, 461\u2013483 (2022).","journal-title":"Annu. Rev. Physiol."},{"key":"36310_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","volume":"184","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 184, 404\u2013421.e16 (2021).","journal-title":"Cell"},{"key":"36310_CR22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ccell.2020.08.014","volume":"38","author":"R Dong","year":"2020","unstructured":"Dong, R. et al. Single-cell characterization of malignant phenotypes and developmental trajectories of adrenal neuroblastoma. Cancer Cell 38, 716\u2013733.e6 (2020).","journal-title":"Cancer Cell"},{"key":"36310_CR23","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cell.2020.07.017","volume":"182","author":"A Maynard","year":"2020","unstructured":"Maynard, A. et al. Therapy-induced evolution of human lung cancer revealed by single-Cell RNA sequencing. Cell 182, 1232\u20131251.e22 (2020).","journal-title":"Cell"},{"key":"36310_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"36310_CR25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.semcancer.2022.06.002","volume":"86","author":"M Braoudaki","year":"2022","unstructured":"Braoudaki, M. et al. Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact. Semin Cancer Biol. 86, 436\u2013449 (2022).","journal-title":"Semin Cancer Biol."},{"key":"36310_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.it.2017.08.004","volume":"38","author":"P Lopez-Cotarelo","year":"2017","unstructured":"Lopez-Cotarelo, P., Gomez-Moreira, C., Criado-Garcia, O., Sanchez, L. & Rodriguez-Fernandez, J. L. Beyond chemoattraction: multifunctionality of chemokine receptors in leukocytes. Trends Immunol. 38, 927\u2013941 (2017).","journal-title":"Trends Immunol."},{"key":"36310_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith, J. W., Sokol, C. L. & Luster, A. D. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev. Immunol. 32, 659\u2013702 (2014).","journal-title":"Annu Rev. Immunol."},{"key":"36310_CR28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cell.2019.09.035","volume":"179","author":"CC Brown","year":"2019","unstructured":"Brown, C. C. et al. Transcriptional basis of mouse and human dendritic cell heterogeneity. Cell 179, 846\u2013863.e24 (2019).","journal-title":"Cell"},{"key":"36310_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.immuni.2019.08.008","volume":"51","author":"CA Dutertre","year":"2019","unstructured":"Dutertre, C. A. et al. Single-cell analysis of human mononuclear phagocytes reveals subset-defining markers and identifies circulating inflammatory dendritic cells. Immunity 51, 573\u2013589.e8 (2019).","journal-title":"Immunity"},{"key":"36310_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1158\/2326-6066.CIR-13-0102","volume":"1","author":"I Mellman","year":"2013","unstructured":"Mellman, I. Dendritic cells: master regulators of the immune response. Cancer Immunol. Res. 1, 145\u2013149 (2013).","journal-title":"Cancer Immunol. Res."},{"key":"36310_CR31","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","volume":"177","author":"M Binnewies","year":"2019","unstructured":"Binnewies, M. et al. Unleashing type-2 dendritic cells to drive protective antitumor CD4(+) T cell immunity. Cell 177, 556\u2013571.e16 (2019).","journal-title":"Cell"},{"key":"36310_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","volume":"44","author":"H Salmon","year":"2016","unstructured":"Salmon, H. et al. Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity 44, 924\u2013938 (2016).","journal-title":"Immunity"},{"key":"36310_CR33","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.immuni.2012.10.018","volume":"38","author":"E Segura","year":"2013","unstructured":"Segura, E. et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38, 336\u2013348 (2013).","journal-title":"Immunity"},{"key":"36310_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.immuni.2012.04.012","volume":"37","author":"M Haniffa","year":"2012","unstructured":"Haniffa, M. et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 37, 60\u201373 (2012).","journal-title":"Immunity"},{"key":"36310_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809.e23 (2021).","journal-title":"Cell"},{"key":"36310_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442\u2013459.e29 (2020).","journal-title":"Cell"},{"key":"36310_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccr.2013.11.007","volume":"24","author":"A Casazza","year":"2013","unstructured":"Casazza, A. et al. Impeding macrophage entry into hypoxic tumor areas by Sema3A\/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell 24, 695\u2013709 (2013).","journal-title":"Cancer Cell"},{"key":"36310_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1470-2045(05)01766-3","volume":"6","author":"M Toi","year":"2005","unstructured":"Toi, M., Atiqur Rahman, M., Bando, H. & Chow, L. W. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol. 6, 158\u2013166 (2005).","journal-title":"Lancet Oncol."},{"key":"36310_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia, L. et al. The cancer metabolic reprogramming and immune response. Mol. cancer 20, 28 (2021).","journal-title":"Mol. cancer"},{"key":"36310_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ccell.2020.09.004","volume":"39","author":"I Kaymak","year":"2021","unstructured":"Kaymak, I., Williams, K. S., Cantor, J. R. & Jones, R. G. Immunometabolic interplay in the tumor microenvironment. Cancer Cell 39, 28\u201337 (2021).","journal-title":"Cancer Cell"},{"key":"36310_CR41","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","volume":"20","author":"RD Leone","year":"2020","unstructured":"Leone, R. D. & Powell, J. D. Metabolism of immune cells in cancer. Nat. Rev. Cancer 20, 516\u2013531 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"36310_CR42","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang, C. H. et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229\u20131241 (2015).","journal-title":"Cell"},{"key":"36310_CR43","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556\u2013W560 (2019).","journal-title":"Nucleic Acids Res."},{"key":"36310_CR44","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829\u2013845.e20 (2019).","journal-title":"Cell"},{"key":"36310_CR45","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293\u20131308.e36 (2018).","journal-title":"Cell"},{"key":"36310_CR46","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.cell.2021.04.038","volume":"184","author":"A Obradovic","year":"2021","unstructured":"Obradovic, A. et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. Cell 184, 2988\u20133005.e16 (2021).","journal-title":"Cell"},{"key":"36310_CR47","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1101\/gad.314617.118","volume":"32","author":"H Gonzalez","year":"2018","unstructured":"Gonzalez, H., Hagerling, C. & Werb, Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 32, 1267\u20131284 (2018).","journal-title":"Genes Dev."},{"key":"36310_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321\u2013330 (2017).","journal-title":"Nature"},{"key":"36310_CR49","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3389\/fimmu.2019.01580","volume":"10","author":"AM Melo","year":"2019","unstructured":"Melo, A. M. et al. Mucosal-associated invariant T cells display diminished effector capacity in oesophageal adenocarcinoma. Front. Immunol. 10, 1580 (2019).","journal-title":"Front. Immunol."},{"key":"36310_CR50","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41577-019-0191-y","volume":"19","author":"A Toubal","year":"2019","unstructured":"Toubal, A., Nel, I., Lotersztajn, S. & Lehuen, A. Mucosal-associated invariant T cells and disease. Nat. Rev. Immunol. 19, 643\u2013657 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"36310_CR51","doi-asserted-by":"publisher","first-page":"eabe1670","DOI":"10.1126\/sciimmunol.abe1670","volume":"5","author":"T Parrot","year":"2020","unstructured":"Parrot, T. et al. MAIT cell activation and dynamics associated with COVID-19 disease severity. Sci. Immunol. 5, eabe1670 (2020).","journal-title":"Sci. Immunol."},{"key":"36310_CR52","doi-asserted-by":"publisher","first-page":"e2001930","DOI":"10.1371\/journal.pbio.2001930","volume":"15","author":"CR Shaler","year":"2017","unstructured":"Shaler, C. R. et al. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression. PLoS Biol. 15, e2001930 (2017).","journal-title":"PLoS Biol."},{"key":"36310_CR53","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","volume":"39","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell 39, 1578\u20131593.e8 (2021).","journal-title":"Cancer Cell"},{"key":"36310_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nature13312","volume":"511","author":"B Ghesquiere","year":"2014","unstructured":"Ghesquiere, B., Wong, B. W., Kuchnio, A. & Carmeliet, P. Metabolism of stromal and immune cells in health and disease. Nature 511, 167\u2013176 (2014).","journal-title":"Nature"},{"key":"36310_CR55","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.immuni.2019.09.003","volume":"51","author":"EH Ma","year":"2019","unstructured":"Ma, E. H. et al. Metabolic profiling using stable isotope tracing reveals distinct patterns of glucose utilization by physiologically activated CD8(+) T cells. Immunity 51, 856\u2013870.e5 (2019).","journal-title":"Immunity"},{"key":"36310_CR56","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li, H. et al. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell 176, 775\u2013789.e18 (2019).","journal-title":"Cell"},{"key":"36310_CR57","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41568-021-00418-1","volume":"22","author":"AA Connor","year":"2021","unstructured":"Connor, A. A. & Gallinger, S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat. Rev. Cancer 22, 131\u2013142 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"36310_CR58","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1126\/science.abh1645","volume":"373","author":"T Ushijima","year":"2021","unstructured":"Ushijima, T., Clark, S. J. & Tan, P. Mapping genomic and epigenomic evolution in cancer ecosystems. Science 373, 1474\u20131479 (2021).","journal-title":"Science"},{"key":"36310_CR59","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.3390\/ijms21218412","volume":"21","author":"J Korbecki","year":"2020","unstructured":"Korbecki, J. et al. CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4. Int. J. Mol. Sci. 21, 8412 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"36310_CR60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","volume":"10","author":"AE Vilgelm","year":"2019","unstructured":"Vilgelm, A. E. & Richmond, A. Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy. Front. Immunol. 10, 333 (2019).","journal-title":"Front. Immunol."},{"key":"36310_CR61","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2017","unstructured":"Li, X. et al. Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 66, 157\u2013167 (2017).","journal-title":"Gut"},{"key":"36310_CR62","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Martinez-Reyes","year":"2021","unstructured":"Martinez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer 21, 669\u2013680 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"36310_CR63","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.trecan.2021.04.007","volume":"7","author":"T Rogers","year":"2021","unstructured":"Rogers, T. & DeBerardinis, R. J. Metabolic plasticity of neutrophils: relevance to pathogen responses and cancer. Trends Cancer 7, 700\u2013713 (2021).","journal-title":"Trends Cancer"},{"key":"36310_CR64","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00262-020-02842-y","volume":"70","author":"V Sasidharan Nair","year":"2021","unstructured":"Sasidharan Nair, V., Saleh, R., Toor, S. M., Cyprian, F. S. & Elkord, E. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment. Cancer Immunol., immunotherapy: CII 70, 2103\u20132121 (2021).","journal-title":"Cancer Immunol., immunotherapy: CII"},{"key":"36310_CR65","doi-asserted-by":"publisher","first-page":"101905","DOI":"10.1016\/j.redox.2021.101905","volume":"41","author":"FB Rashed","year":"2021","unstructured":"Rashed, F. B. et al. Identification of proteins and cellular pathways targeted by 2-nitroimidazole hypoxic cytotoxins. Redox Biol. 41, 101905 (2021).","journal-title":"Redox Biol."},{"key":"36310_CR66","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1021\/acs.accounts.0c00431","volume":"54","author":"A Sengupta","year":"2021","unstructured":"Sengupta, A., Roy, S. S. & Chowdhury, S. Non-duplex G-Quadruplex DNA structure: a developing story from predicted sequences to DNA structure-dependent epigenetics and beyond. Acc. Chem. Res. 54, 46\u201356 (2021).","journal-title":"Acc. Chem. Res."},{"key":"36310_CR67","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nature26140","volume":"555","author":"SK Hindupur","year":"2018","unstructured":"Hindupur, S. K. et al. The protein histidine phosphatase LHPP is a tumour suppressor. Nature 555, 678\u2013682 (2018).","journal-title":"Nature"},{"key":"36310_CR68","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","volume":"39","author":"K Bi","year":"2021","unstructured":"Bi, K. et al. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell 39, 649\u2013661.e5 (2021).","journal-title":"Cancer Cell"},{"key":"36310_CR69","doi-asserted-by":"publisher","first-page":"1846915","DOI":"10.1080\/2162402X.2020.1846915","volume":"9","author":"RA de Azevedo","year":"2020","unstructured":"de Azevedo, R. A. et al. MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma. Oncoimmunology 9, 1846915 (2020).","journal-title":"Oncoimmunology"},{"key":"36310_CR70","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal, A. A. et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature 572, 392\u2013396 (2019).","journal-title":"Nature"},{"key":"36310_CR71","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12520","volume":"276","author":"M Das","year":"2017","unstructured":"Das, M., Zhu, C. & Kuchroo, V. K. Tim-3 and its role in regulating anti-tumor immunity. Immunol. Rev. 276, 97\u2013111 (2017).","journal-title":"Immunol. Rev."},{"key":"36310_CR72","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-13-1504","volume":"74","author":"JL Lines","year":"2014","unstructured":"Lines, J. L. et al. VISTA is an immune checkpoint molecule for human T cells. Cancer Res. 74, 1924\u20131932 (2014).","journal-title":"Cancer Res."},{"key":"36310_CR73","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1158\/2159-8290.CD-20-0962","volume":"11","author":"MF Sanmamed","year":"2021","unstructured":"Sanmamed, M. F. et al. A burned-Out CD8(+) T-cell subset expands in the tumor microenvironment and curbs cancer immunotherapy. Cancer Discov. 11, 1700\u20131715 (2021).","journal-title":"Cancer Discov."},{"key":"36310_CR74","doi-asserted-by":"publisher","first-page":"e51806","DOI":"10.15252\/embr.202051806","volume":"22","author":"MD Radyk","year":"2021","unstructured":"Radyk, M. D. et al. ATF3 induces RAB7 to govern autodegradation in paligenosis, a conserved cell plasticity program. EMBO Rep. 22, e51806 (2021).","journal-title":"EMBO Rep."},{"key":"36310_CR75","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1080\/15548627.2020.1857080","volume":"17","author":"ZF Miao","year":"2021","unstructured":"Miao, Z. F., Cho, C. J., Wang, Z. N. & Mills, J. C. Autophagy repurposes cells during paligenosis. Autophagy 17, 588\u2013589 (2021).","journal-title":"Autophagy"},{"key":"36310_CR76","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/j.gastro.2020.09.016","volume":"160","author":"ZF Miao","year":"2021","unstructured":"Miao, Z. F. et al. DDIT4 licenses only healthy cells to proliferate during injury-induced metaplasia. Gastroenterology 160, 260\u2013271.e10 (2021).","journal-title":"Gastroenterology"},{"key":"36310_CR77","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.devcel.2020.07.005","volume":"55","author":"ZF Miao","year":"2020","unstructured":"Miao, Z. F. et al. A dedicated evolutionarily conserved molecular network licenses differentiated cells to return to the cell cycle. Dev. Cell 55, 178\u2013194.e7 (2020).","journal-title":"Dev. Cell"},{"key":"36310_CR78","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nature13255","volume":"510","author":"JT Rodgers","year":"2014","unstructured":"Rodgers, J. T. et al. mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert). Nature 510, 393\u2013396 (2014).","journal-title":"Nature"},{"key":"36310_CR79","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/j.gastro.2021.10.036","volume":"162","author":"JR Goldenring","year":"2021","unstructured":"Goldenring, J. R. & Mills, J. C. Cellular plasticity, reprogramming, and regeneration: metaplasia in the stomach and beyond. Gastroenterology 162, 415\u2013430 (2021).","journal-title":"Gastroenterology"},{"key":"36310_CR80","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","volume":"21","author":"AW Lambert","year":"2021","unstructured":"Lambert, A. W. & Weinberg, R. A. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat. Rev. Cancer 21, 325\u2013338 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"36310_CR81","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","volume":"17","author":"A Quintanal-Villalonga","year":"2020","unstructured":"Quintanal-Villalonga, A. et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat. Rev. Clin. Oncol. 17, 360\u2013371 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"36310_CR82","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41568-019-0154-4","volume":"19","author":"I Arozarena","year":"2019","unstructured":"Arozarena, I. & Wellbrock, C. Phenotype plasticity as enabler of melanoma progression and therapy resistance. Nat. Rev. Cancer 19, 377\u2013391 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"36310_CR83","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/2159-8290.CD-19-0015","volume":"9","author":"S Yuan","year":"2019","unstructured":"Yuan, S., Norgard, R. J. & Stanger, B. Z. Cellular plasticity in cancer. Cancer Discov. 9, 837\u2013851 (2019).","journal-title":"Cancer Discov."},{"key":"36310_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jcmgh.2021.09.005","volume":"13","author":"MJ Pang","year":"2022","unstructured":"Pang, M. J. et al. Gastric organoids: progress and remaining challenges. Cell. Mol. Gastroenterol. Hepatol. 13, 19\u201333 (2022).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"36310_CR85","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41418-020-00662-2","volume":"28","author":"T Seidlitz","year":"2021","unstructured":"Seidlitz, T., Koo, B. K. & Stange, D. E. Gastric organoids-an in vitro model system for the study of gastric development and road to personalized medicine. Cell Death Differ. 28, 68\u201383 (2021).","journal-title":"Cell Death Differ."},{"key":"36310_CR86","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost, J. & Clevers, H. Organoids in cancer research. Nat. Rev. Cancer 18, 407\u2013418 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"36310_CR87","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.it.2018.11.001","volume":"40","author":"MJ Schuijs","year":"2019","unstructured":"Schuijs, M. J., Hammad, H. & Lambrecht, B. N. Professional and \u2018Amateur\u2019 antigen-presenting cells in type 2 immunity. Trends Immunol. 40, 22\u201334 (2019).","journal-title":"Trends Immunol."},{"key":"36310_CR88","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","volume":"37","author":"A Gardner","year":"2016","unstructured":"Gardner, A. & Ruffell, B. Dendritic cells and cancer immunity. Trends Immunol. 37, 855\u2013865 (2016).","journal-title":"Trends Immunol."},{"key":"36310_CR89","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nri3818","volume":"15","author":"PA Roche","year":"2015","unstructured":"Roche, P. A. & Furuta, K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203\u2013216 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"36310_CR90","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado, H. et al. Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer 17, 302\u2013317 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"36310_CR91","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu, Y. & Cao, X. Characteristics and significance of the pre-metastatic niche. Cancer Cell 30, 668\u2013681 (2016).","journal-title":"Cancer Cell"},{"key":"36310_CR92","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1158\/0008-5472.CAN-15-1695","volume":"76","author":"G Bakdash","year":"2016","unstructured":"Bakdash, G. et al. Expansion of a BDCA1+CD14+ myeloid cell population in melanoma patients may attenuate the efficacy of dendritic cell vaccines. Cancer Res. 76, 4332\u20134346 (2016).","journal-title":"Cancer Res."},{"key":"36310_CR93","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1158\/0008-5472.CAN-18-0933","volume":"78","author":"AR Sanchez-Paulete","year":"2018","unstructured":"Sanchez-Paulete, A. R. et al. Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant semliki forest virus-derived vectors fosters dendritic cell-mediated T-cell cross-priming. Cancer Res. 78, 6643\u20136654 (2018).","journal-title":"Cancer Res."},{"key":"36310_CR94","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","volume":"36","author":"A Zlotnik","year":"2012","unstructured":"Zlotnik, A. & Yoshie, O. The chemokine superfamily revisited. Immunity 36, 705\u2013716 (2012).","journal-title":"Immunity"},{"key":"36310_CR95","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","volume":"69","author":"H Harlin","year":"2009","unstructured":"Harlin, H. et al. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res. 69, 3077\u20133085 (2009).","journal-title":"Cancer Res."},{"key":"36310_CR96","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2021","unstructured":"Kumar, V. et al. Single-cell atlas of lineage states, tumor microenvironment and subtype-specific expression programs in gastric cancer. Cancer Discov. 12, 670\u2013691 (2021).","journal-title":"Cancer Discov."},{"key":"36310_CR97","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research, N.","year":"2014","unstructured":"Cancer Genome Atlas Research, N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202\u2013209 (2014).","journal-title":"Nature"},{"key":"36310_CR98","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper, J. & Giancotti, F. G. Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell 35, 347\u2013367 (2019).","journal-title":"Cancer Cell"},{"key":"36310_CR99","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.stem.2018.11.011","volume":"24","author":"PB Gupta","year":"2019","unstructured":"Gupta, P. B., Pastushenko, I., Skibinski, A., Blanpain, C. & Kuperwasser, C. Phenotypic plasticity: driver of cancer initiation, progression, and therapy resistance. Cell Stem cell 24, 65\u201378 (2019).","journal-title":"Cell Stem cell"},{"key":"36310_CR100","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik, D. & Lathia, J. D. Cancer stem cell-immune cell crosstalk in tumour progression. Nat. Rev. Cancer 21, 526\u2013536 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"36310_CR101","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2018.11.017","volume":"24","author":"C Saygin","year":"2019","unstructured":"Saygin, C., Matei, D., Majeti, R., Reizes, O. & Lathia, J. D. Targeting cancer stemness in the clinic: from hype to hope. Cell Stem Cell 24, 25\u201340 (2019).","journal-title":"Cell Stem Cell"},{"key":"36310_CR102","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124\u20131134 (2017).","journal-title":"Nat. Med."},{"key":"36310_CR103","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue, T. & Weinberg, R. A. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat. Rev. Clin. Oncol. 14, 611\u2013629 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"36310_CR104","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux, K. & Delgoffe, G. M. Metabolic barriers to cancer immunotherapy. Nat. Rev. Immunol. 21, 785\u2013797 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"36310_CR105","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812\u2013830.e14 (2018).","journal-title":"Immunity"},{"key":"36310_CR106","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","volume":"28","author":"CL Jones","year":"2021","unstructured":"Jones, C. L., Inguva, A. & Jordan, C. T. Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors. Cell Stem Cell 28, 378\u2013393 (2021).","journal-title":"Cell Stem Cell"},{"key":"36310_CR107","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.trecan.2020.12.014","volume":"7","author":"LP Ferguson","year":"2021","unstructured":"Ferguson, L. P., Diaz, E. & Reya, T. The role of the microenvironment and immune system in regulating stem cell fate in cancer. Trends Cancer 7, 624\u2013634 (2021).","journal-title":"Trends Cancer"},{"key":"36310_CR108","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.tips.2020.09.008","volume":"41","author":"AF Stoica","year":"2020","unstructured":"Stoica, A. F., Chang, C. H. & Pauklin, S. Molecular therapeutics of pancreatic ductal adenocarcinoma: targeted pathways and the role of cancer stem cells. Trends Pharmacol. Sci. 41, 977\u2013993 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"36310_CR109","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","volume":"24","author":"BC Prager","year":"2019","unstructured":"Prager, B. C., Xie, Q., Bao, S. & Rich, J. N. Cancer stem cells: the architects of the tumor ecosystem. Cell Stem Cell 24, 41\u201353 (2019).","journal-title":"Cell Stem Cell"},{"key":"36310_CR110","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","volume":"352","author":"QM Fan","year":"2014","unstructured":"Fan, Q. M. et al. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett. 352, 160\u2013168 (2014).","journal-title":"Cancer Lett."},{"key":"36310_CR111","doi-asserted-by":"publisher","first-page":"12425","DOI":"10.1073\/pnas.1106645108","volume":"108","author":"M Jinushi","year":"2011","unstructured":"Jinushi, M. et al. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem\/initiating cells. Proc. Natl Acad. Sci. USA 108, 12425\u201312430 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"36310_CR112","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2014.01.005","volume":"14","author":"A Pietras","year":"2014","unstructured":"Pietras, A. et al. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. Cell Stem Cell 14, 357\u2013369 (2014).","journal-title":"Cell Stem Cell"},{"key":"36310_CR113","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/1535370213480714","volume":"238","author":"K Williams","year":"2013","unstructured":"Williams, K., Motiani, K., Giridhar, P. V. & Kasper, S. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches. Exp. Biol. Med. 238, 324\u2013338 (2013).","journal-title":"Exp. Biol. Med."},{"key":"36310_CR114","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc3023","volume":"11","author":"M Zoller","year":"2011","unstructured":"Zoller, M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer 11, 254\u2013267 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"36310_CR115","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis, U. A. et al. Ovarian cancer. Nat. Rev. Dis. Prim. 2, 16061 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"36310_CR116","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","volume":"26","author":"B Izar","year":"2020","unstructured":"Izar, B. et al. A single-cell landscape of high-grade serous ovarian cancer. Nat. Med. 26, 1271\u20131279 (2020).","journal-title":"Nat. Med."},{"key":"36310_CR117","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick, F. et al. Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33, 1005\u20131020 (2022).","journal-title":"Ann. Oncol."},{"key":"36310_CR118","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1055\/a-1811-7025","volume":"54","author":"P Pimentel-Nunes","year":"2022","unstructured":"Pimentel-Nunes, P. et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy 54, 591\u2013622 (2022).","journal-title":"Endoscopy"},{"key":"36310_CR119","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/den.13883","volume":"33","author":"H Ono","year":"2021","unstructured":"Ono, H. et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig. Endosc. 33, 4\u201320 (2021).","journal-title":"Dig. Endosc."},{"key":"36310_CR120","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1016\/S0140-6736(16)30354-3","volume":"388","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem, E., Sagaert, X., Topal, B., Haustermans, K. & Prenen, H. Gastric cancer. Lancet 388, 2654\u20132664 (2016).","journal-title":"Lancet"},{"key":"36310_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gie.2015.03.1967","volume":"82","author":"Committee, A.S.O.P.","year":"2015","unstructured":"Committee, A.S.O.P. et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest. Endosc. 82, 1\u20138 (2015).","journal-title":"Gastrointest. Endosc."},{"key":"36310_CR122","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"Japanese Gastric Cancer, A.","year":"2011","unstructured":"Japanese Gastric Cancer, A. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14, 101\u2013112 (2011).","journal-title":"Gastric Cancer"},{"key":"36310_CR123","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329\u2013337.e4 (2019).","journal-title":"Cell Syst."},{"key":"36310_CR124","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e21 (2019).","journal-title":"Cell"},{"key":"36310_CR125","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"36310_CR126","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","volume":"184","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184, 1895\u20131913.e19 (2021).","journal-title":"Cell"},{"key":"36310_CR127","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41586-022-04461-2","volume":"603","author":"R Palovics","year":"2022","unstructured":"Palovics, R. et al. Molecular hallmarks of heterochronic parabiosis at single-cell resolution. Nature 603, 309\u2013314 (2022).","journal-title":"Nature"},{"key":"36310_CR128","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ccell.2021.10.001","volume":"39","author":"L Au","year":"2021","unstructured":"Au, L. et al. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. Cancer Cell 39, 1497\u20131518.e11 (2021).","journal-title":"Cancer Cell"},{"key":"36310_CR129","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"36310_CR130","doi-asserted-by":"publisher","first-page":"eaai8478","DOI":"10.1126\/science.aai8478","volume":"355","author":"AS Venteicher","year":"2017","unstructured":"Venteicher, A. S. et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355, eaai8478 (2017).","journal-title":"Science"},{"key":"36310_CR131","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"36310_CR132","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"36310_CR133","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Single-cell mRNA quantification and differential analysis with census. Nat. Methods 14, 309\u2013315 (2017).","journal-title":"Nat. Methods"},{"key":"36310_CR134","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"36310_CR135","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat. Med. 24, 978\u2013985 (2018).","journal-title":"Nat. Med."},{"key":"36310_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13041","volume":"7","author":"E Gaude","year":"2016","unstructured":"Gaude, E. & Frezza, C. Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival. Nat. Commun. 7, 13041 (2016).","journal-title":"Nat. Commun."},{"key":"36310_CR137","doi-asserted-by":"publisher","first-page":"bav006","DOI":"10.1093\/database\/bav006","volume":"2015","author":"F Belinky","year":"2015","unstructured":"Belinky, F. et al. PathCards: multi-source consolidation of human biological pathways. Database 2015, bav006 (2015).","journal-title":"Database"},{"key":"36310_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"36310_CR139","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"36310_CR140","first-page":"D498","volume":"48","author":"B Jassal","year":"2020","unstructured":"Jassal, B. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 48, D498\u2013D503 (2020).","journal-title":"Nucleic Acids Res."},{"key":"36310_CR141","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"36310_CR142","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284\u2013287 (2012).","journal-title":"Omics"},{"key":"36310_CR143","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"36310_CR144","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova, M., Vento-Tormo, M., Teichmann, S. A. & Vento-Tormo, R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc. 15, 1484\u20131506 (2020).","journal-title":"Nat. Protoc."},{"key":"36310_CR145","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36310-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36310-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36310-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:12:50Z","timestamp":1676362370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36310-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":145,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36310"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-36310-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"822"}}